Discontinuation report AMERGE
| Report ID | 148430 |
| Drug Identification Number | 02237821 |
| Brand name | AMERGE |
| Common or Proper name | Naratriptan Tablets |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NARATRIPTAN |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | All pack sizes / Tous les formats |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2022-12-01 |
| Remaining supply date | 2024-02-17 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-12-02 | French | Compare |
| v5 | 2022-12-02 | English | Compare |
| v4 | 2022-11-09 | French | Compare |
| v3 | 2022-11-09 | English | Compare |
| v2 | 2021-10-28 | French | Compare |
| v1 | 2021-10-28 | English | Compare |
Showing 1 to 6 of 6